Update: An October 2024 Clinical Practice Guidance joint statement by multiple medical societies (American Society of Anesthesiologists (ASA), American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons) states that most patients should continue taking their GLP-1 drugs before elective surgery
Regulatory assessments and population pharmacokinetic modelling show that: Tirzepatide half-life is around 55.7 days, Concentrations reach the lower limit of quantitation about 4 weeks after a steady-state dose, The accumulation ratio with weekly dosing is about 1.7, meaning steady-state exposure is roughly 1.7 times higher than after a single dose
On Day 1, the eight yes votes were the eight temporary members added to the committee shortly before the meeting
However, the absence of a formal warning does not guarantee safety
SNAC was associated with increased gestation length, stillbirths, and decreased pup viability following oral dosing in pregnant rats during gestation and lactation
What Does the Research Actually Show - and What Does It Not Show Yet This is the section most advertorial content skips or glosses over
